PL3528829T3 - Koniugaty bacytracyna-oligomer alginianowy - Google Patents

Koniugaty bacytracyna-oligomer alginianowy

Info

Publication number
PL3528829T3
PL3528829T3 PL17787188.6T PL17787188T PL3528829T3 PL 3528829 T3 PL3528829 T3 PL 3528829T3 PL 17787188 T PL17787188 T PL 17787188T PL 3528829 T3 PL3528829 T3 PL 3528829T3
Authority
PL
Poland
Prior art keywords
bacitracin
alginate oligomer
oligomer conjugates
conjugates
alginate
Prior art date
Application number
PL17787188.6T
Other languages
English (en)
Inventor
Elaine Ferguson
David William Thomas
Arne Dessen
Philip Rye
Original Assignee
Algipharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma As filed Critical Algipharma As
Publication of PL3528829T3 publication Critical patent/PL3528829T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C07K7/58Bacitracins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PL17787188.6T 2016-10-21 2017-10-20 Koniugaty bacytracyna-oligomer alginianowy PL3528829T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1617862.6A GB2555391B (en) 2016-10-21 2016-10-21 Bacitracin-alginate oligomer conjugates
PCT/EP2017/076926 WO2018073448A1 (en) 2016-10-21 2017-10-20 Bacitracin-alginate oligomer conjugates

Publications (1)

Publication Number Publication Date
PL3528829T3 true PL3528829T3 (pl) 2022-09-19

Family

ID=57738026

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17787188.6T PL3528829T3 (pl) 2016-10-21 2017-10-20 Koniugaty bacytracyna-oligomer alginianowy

Country Status (16)

Country Link
US (1) US20230139922A1 (pl)
EP (1) EP3528829B1 (pl)
JP (1) JP7191014B2 (pl)
KR (1) KR20190070946A (pl)
CN (1) CN109862904A (pl)
AU (1) AU2017345294A1 (pl)
BR (1) BR112019007928A2 (pl)
CA (1) CA3040796A1 (pl)
DK (1) DK3528829T3 (pl)
ES (1) ES2914784T3 (pl)
GB (1) GB2555391B (pl)
PL (1) PL3528829T3 (pl)
PT (1) PT3528829T (pl)
RU (1) RU2766345C2 (pl)
SI (1) SI3528829T1 (pl)
WO (1) WO2018073448A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110484473B (zh) * 2019-08-31 2022-08-19 暨南大学 一种促进鹤羽田戴尔福特菌在植物根际定殖的方法
CN111057131A (zh) * 2019-12-13 2020-04-24 上海市食品药品检验所 一种杆菌肽及其组分的分析方法
CN111420024B (zh) * 2020-04-07 2023-10-03 中国科学院深圳先进技术研究院 杆菌酞a在制备预防和治疗冠状病毒的药物中的应用
CN112812150A (zh) * 2021-01-29 2021-05-18 深圳海创生物科技有限公司 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用
CN113413490B (zh) * 2021-05-14 2022-05-27 哈尔滨医科大学 一种超声响应性复合水凝胶及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US6248360B1 (en) * 2000-06-21 2001-06-19 International Health Management Associates, Inc. Complexes to improve oral absorption of poorly absorbable antibiotics
JP5639475B2 (ja) 2007-11-27 2014-12-10 アルギファルマ アイピーアール エーエス バイオフィルムと闘う際のアルギネートオリゴマーの使用
EP2161020A1 (en) * 2008-09-09 2010-03-10 Koninklijke Philips Electronics N.V. Chelating amphiphilic polymers
JP5202763B2 (ja) * 2009-06-03 2013-06-05 アルギファルマ エーエス アルギネートオリゴマーと抗生物質とによるアシネトバクター感染の治療
CN103857440B (zh) 2011-06-22 2018-09-25 维奥姆生物科学有限公司 基于缀合物的抗真菌和抗细菌前药
WO2016081820A1 (en) * 2014-11-20 2016-05-26 University Of Southern California Use of alginate formulation for intraincisional drug delivery

Also Published As

Publication number Publication date
GB201617862D0 (en) 2016-12-07
CA3040796A1 (en) 2018-04-26
PT3528829T (pt) 2022-06-02
EP3528829B1 (en) 2022-03-02
CN109862904A (zh) 2019-06-07
GB2555391B (en) 2019-06-26
SI3528829T1 (sl) 2022-07-29
ES2914784T3 (es) 2022-06-16
DK3528829T3 (da) 2022-05-30
AU2017345294A1 (en) 2019-05-02
JP7191014B2 (ja) 2022-12-16
WO2018073448A1 (en) 2018-04-26
GB2555391A (en) 2018-05-02
RU2766345C2 (ru) 2022-03-15
US20230139922A1 (en) 2023-05-04
RU2019109728A3 (pl) 2021-02-16
BR112019007928A2 (pt) 2019-07-02
RU2019109728A (ru) 2020-11-23
JP2019535669A (ja) 2019-12-12
KR20190070946A (ko) 2019-06-21
EP3528829A1 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
IL285516B (en) Amatoxin antibody conjugates
ZA201904269B (en) Pyrrolobenzodiazepine-antibody conjugates
IL248526A0 (en) Oligomers and oligomer conjugates
RS61795B1 (sr) Konjugati pirolobenzodiazepin antitela
GB201513607D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201702031D0 (en) Pyrrolobenzodiazepine-antibody conjugates
PL3528829T3 (pl) Koniugaty bacytracyna-oligomer alginianowy
GB201504694D0 (en) Covalent conjugates
HK1257229A1 (zh) Cck2r-藥物偶聯物
PL3270711T3 (pl) Koniugaty cukier-dipeptyd
SG10201506686WA (en) Conjugates
GB201714710D0 (en) Polymyxin-alginate oligomer conjugates
GB201617860D0 (en) Polymyxin-alginate oligomer conjugates
GB201721290D0 (en) Conjugates
GB201719906D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719398D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719393D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719391D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201706466D0 (en) pyrrolobenzodiazepine-peptide conjugates
GB201702029D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201518839D0 (en) Conjugates
GB201513605D0 (en) Pyrrolobenzodiazepine-antibody conjugates